Site as a Prognostic Factor in Patients With Stage III/IV Squamous Cell Carcinoma of the Head and Neck Following Definitive Chemoradiation

K. Carter(University of Maryland, Baltimore), M. Suntharalingam(University of Maryland, Baltimore), R. Taylor(University of Oxford), Kathleen Settle(University of Maryland, Baltimore), Young Kwok(University of Maryland, Baltimore), Ann B. Zimrin(University of Maryland, Baltimore), Jeffrey S. Wolf(University of Maryland, Baltimore), K. Cullen(University of Maryland, Baltimore), R.A. Ord(University of Maryland, Baltimore), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
International Journal of Radiation Oncology*Biology*Physics
October 2, 2007
10.1016/j.ijrobp.2007.07.1658
Cited by 2

Related Papers

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
CONSORT 2025 statement: updated guideline for reporting randomised trials
|BMJ|2025|847
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
|PubMed|2003|492